GLP-1 drugs are FDA-approved to treat a variety of health conditions, including Type 2 diabetes and obesity
Owing to the following health risks, CJC-1295 and ipamorelin are moderately unsafe for the general population compared to some of the other peptides weve studied: Immunogenicity: Immunogenicity is a condition in which your body interprets a substance as a threat and mounts an immune response against it
Medical News Today, 2026
Carelon makes connected care possible for everyone by putting people at the center of what we do and delivering the right balance of care, technology, data-driven insights and expertise to solve complex challenges and help consumers lead healthier lives, Pete Haytaian, who is executive vice president of Anthem, and president of Carelon, which the company said serves one in three people in the U.S
The STEP trials demonstrated that semaglutide produced weight loss in a dose-dependent manner, with participants on the 2.4 mg weekly dose experiencing average weight reductions of 15% at 68 weeks compared to 2.7% in the placebo group